Precision AI For Early Detection
and Immune Rejuvenation.

Data-Driven Precision Care to Restore Health and Extend Healthspan.

Healthier Lives Accessible to All.

Scalable platform powered by human-based data to unlock novel
biomarkers and immune rejuvenation medicine.

Interdisciplinary team with deep domain expertise

Addressing complex age-related diseases

Cancer

Solid tumors

Inflammation

Immune dysregulation

Neurodegenerative

Immune dysregulation

Supported by

Accomplishments and Growing Traction

CelineBio’s CEO got invited to the incredible Annual Galien Forum at the Alexandria Center for Life Science. Texas Medical Center won the Prix Galien USA 2024 in the category of Best Incubator, Accelerator, Equity! According to the The Galien Foundation, “Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical research. It is now the most prestigious award of its kind in 11 countries”.

CelineBio’s CEO got invited by Johnson & Johnson to moderate Women In Bio-San Francisco Bay Area event

CelineBio have successfully graduated from Texas Medical Center Innovation Factory program for “Cancer-Fighting Cohort of Innovators”. TMC is the largest medical center in the world and is home to the No.1 hospital for cancer care, MD Anderson Cancer Center

CelineBio was selected to showcase our innovative tech-bio platform during the BioTools Innovator 2024 Road Tour in San Diego

CelineBio got accepted to the Texas Medical Center Innovation Factory program for “Cancer-Fighting Cohort of Innovators”. TMC is the largest medical center in the world and is home to the No.1 hospital for cancer care, MD Anderson Cancer Center.

CelineBio got invited to the Memorial Sloan Kettering Cancer Center Life Sciences Innovation Summit

CelineBio got selected for Pear VC’s inaugural PFC program

CelineBio got accepted to the Johnson & Johnson Innovation Lab and achieved “Health Equity Hero” in recognition of commitment to health equity in innovation

CelineBio got accepted to present our innovation solution at BioLabs Investor Day

CelineBio’s CEO was invited to highlighting the power of AI in precision medicine.

CelineBio was selected as the Finalist by Novo Nordisk's Bio Innovation Hub.

CelineBio was selected as the finalist for Johnson & Johnson Innovation and California Life Sciences (CLS) QuickPitch Poster session

CelineBio was selected as an inaugural member of the Merck Digital Sciences Studio. (only 12 accepted out of +200 companies)

READY TO MAKE AN IMPACT?

Together we can restore human health and extend healthspan.
Contact CelineBio today at [email protected] to start your journey.

Follow CelineBio on:

Contact: [email protected]